H. Rabenau
About
In The Last Decade
H. Rabenau
15 papers receiving 315 citations
Peers
Comparison fields: 5 of 63
- Epidemiology 198
- Hepatology 103
- Oncology 59
- Infectious Diseases 50
- Molecular Biology 43
Countries citing papers authored by H. Rabenau
This map shows the geographic impact of H. Rabenau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Rabenau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Rabenau more than expected).
Fields of papers citing papers by H. Rabenau
This network shows the impact of papers produced by H. Rabenau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Rabenau. The network helps show where H. Rabenau may publish in the future.
Co-authorship network of co-authors of H. Rabenau
This figure shows the co-authorship network connecting the top 25 collaborators of H. Rabenau. A scholar is included among the top collaborators of H. Rabenau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Rabenau. H. Rabenau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 33 | |
| 5 | 17 | |
| 6 | 116 | |
| 7 | 14 | |
| 8 | Increased efficacy of aphidicolin killing of human neuroblastoma cells in vitro by encapsulation in liposomes. | 1 |
| 9 | 85 | |
| 10 | [Selective inhibition of replication of human cytomegalovirus by desferrioxamine in vitro and in vivo (case report)]. | 6 |
| 11 | In vitro anti-human cytomegalovirus activity of liposome-encapsulated foscarnet. | 5 |
| 12 | 18 | |
| 13 | 8 | |
| 14 | 2 | |
| 15 | 14 | |
| 16 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.